Towards comprehensive characterization of HER2 overexpression

par Berezov, Alan, Greene, Mark I
Publié 2006

Mechanisms of resistance to ErbB-targeted cancer therapeutics

par Wang, Qiang, Greene, Mark I.
Publié 2008

Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells – how diverse signals regulate suppression

par Li, Bin, Greene, Mark I
Publié 2008

Cooperative regulatory events and Foxp3 expression

par Tone, Masahide, Greene, Mark I.
Publié 2011

Structure Based Antibody-Like Peptidomimetics

par Murali, Ramachandran, Greene, Mark I.
Publié 2012

Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vβ8.1 transgenic mice

par Maeda, Hironori, Fujimoto, Shigeyoshi, Greene, Mark I.
Publié 2000

Genetic and molecular aspects of demyelination

par Gonatas, Nicholas K., Greene, Mark I., Waksman, Byron H.
Publié dans Immunol Today (1986)

Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19

par Cai, Zheng, Greene, Mark I., Zhu, Zhiqiang, Zhang, Hongtao
Publié dans Antibodies (Basel) (2020)

Ca(2+) and K(+) (BK) channels in chick hair cells are clustered and colocalized with apical–basal and tonotopic gradients

par Samaranayake, Haresha, Saunders, James C, Greene, Mark I, Navaratnam, Dhasakumar S
Publié 2004

Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood

par Freudenberg, Jaclyn A., Bembas, Kathryn, Greene, Mark I., Zhang, Hongtao
Publié 2008

Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT)

par Cai, Zheng, Zhu, Zhiqiang, Greene, Mark I, Cines, Douglas B
Publié dans Autoimmun Rev (2016)

CD147 Immunoglobulin Superfamily Receptor Function and Role in Pathology

par Iacono, Kathryn T., Brown, Amy L., Greene, Mark I., Saouaf, Sandra J.
Publié 2007

Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: A mechanism for aneuploidy in cancer

par Liu, Qingdu, Hirohashi, Yoshihiko, Du, Xiulian, Greene, Mark I., Wang, Qiang
Publié 2009

Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity

par Zhang, Hongtao, Xiao, Yan, Zhu, Zhiqiang, Li, Bin, Greene, Mark I
Publié 2011

Expression and function of ErbB receptors and ligands in the pituitary

par Cooper, Odelia, Vlotides, George, Fukuoka, Hidenori, Greene, Mark I., Melmed, Shlomo
Publié 2011

Lysosome-dependent p300/FOXP3 degradation and limits T(reg) cell functions and enhances targeted therapy against cancers

par Du, Taofeng, Nagai, Yasuhiro, Xiao, Yan, Greene, Mark I., Zhang, Hongtao
Publié 2013

PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling

par Tanaka, Yukinori, Nagai, Yasuhiro, Okumura, Mariko, Greene, Mark I., Kambayashi, Taku
Publié dans Front Immunol (2020)

FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions

par Grover, Payal, Goel, Peeyush N., Piccirillo, Ciriaco A., Greene, Mark I.
Publié dans Front Pediatr (2021)

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3(+) regulatory T cells

par Wang, Liqing, de Zoeten, Edwin F., Greene, Mark I., Hancock, Wayne W.
Publié 2009

Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis

par Morvaridi, Susan, Dhall, Deepti, Greene, Mark I., Pandol, Stephen J., Wang, Qiang
Publié dans Sci Rep (2015)